does hsa pay for semaglutide FSA Eligible Compounded HSA & FSA accounts approved

First introduced by Novo Nordisk in 2026, oral semaglutide became the first of its kind approved specifically for weight management, differentiating itself from brands like Rybelsus, which is targeted at type 2 diabetes

The inclusion of GIPR agonism in Retatrutides profile distinguishes it from GLP-1-only agonists and allows for comparative research into GIP-specific contributions to metabolic regulation

However, the side effects profile mainly depends on an individuals tolerance, body metabolism, genetics, lifestyle habits, and health conditions

A : Googeer GLP-1 may have a moderate effect on your GLP-1 levels

Some people may lose 35 percent